Skip to main content

Find Clinical Trials

Home
Conditions
Stage III T Lymphoblastic Leukemia/Lymphoma

Clinical trial condition

Stage III T Lymphoblastic Leukemia/Lymphoma

Explore clinical trials studying Stage III T Lymphoblastic Leukemia/Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III T Lymphoblastic Leukemia/Lymphoma trial results

Not Yet Recruiting

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

NCT07072585

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Not specified

View Trial Details